Isorhamnetin represses adipogenesis in 3T3-L1 cells (Q42807287)

7 November 2017

Isorhamnetin represses adipogenesis in 3T3-L1 cells (English)

1 reference

7 November 2017

1 reference

Jongsung Lee

1

1 reference

7 November 2017

Eunsun Jung

2

1 reference

7 November 2017

Jienny Lee

3

1 reference

7 November 2017

Saebom Kim

4

1 reference

7 November 2017

Sungran Huh

5

1 reference

7 November 2017

Youngsoo Kim

6

1 reference

7 November 2017

Yongwoo Kim

7

1 reference

7 November 2017

Sang Yo Byun

8

1 reference

7 November 2017

Yeong-Shik Kim

9

1 reference

7 November 2017

Deokhoon Park

10

1 reference

7 November 2017

23 October 2008

1 reference

7 November 2017

1 reference

7 November 2017

17

1 reference

7 November 2017

226-232

1 reference

7 November 2017

2

1 reference

Adipose tissue and atherothrombosis

7 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Alpha-lipoic acid inhibits adipocyte differentiation by regulating pro-adipogenic transcription factors via mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Transcriptional control of adipocyte formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Retinaldehyde represses adipogenesis and diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Adipocytes as regulators of energy balance and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Properties of quercetin conjugates: modulation of LDL oxidation and binding to human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Flavonoids: antioxidants or signalling molecules?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Isorhamnetin prevent endothelial cell injuries from oxidized LDL via activation of p38MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Nitric oxide dysregulates adipocytokine expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Protein kinase C is involved in the regulation of hairless mRNA expression during mouse keratinocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Gap-junctional communication is required for mitotic clonal expansion during adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

C/EBPalpha regulates human adiponectin gene transcription through an intronic enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Repressive effect of Sp1 on the C/EBPalpha gene promoter: role in adipocyte differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Drug treatment of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.472

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2008.472

1 reference

release_xsj57rhkffgm3avjhfdhljbbym

7 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xsj57rhkffgm3avjhfdhljbbym

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference